PubMed (MeSH Keyword) for id: 40854

Year	Number of Results
1975	1
1976	1
1977	4
1978	5
1979	7
1980	10
1981	16
1982	10
1983	7
1984	12
1985	14
1986	13
1987	14
1988	16
1989	11
1990	9
1991	10
1992	9
1993	16
1994	8
1995	9
1996	13
1997	13
1998	7
1999	6
2000	7
2001	2
2002	7
2003	2
2004	2
2005	3
2006	13
2007	5
2008	3
2009	5
2010	5
2011	4
2012	6
2013	6
2014	3
2015	4
2016	2
2017	4
2018	6
2019	8
2020	4
2021	8
2022	5
2023	2
2024	1

1

Concurrent use of two dual-combination drenches containing monepantel/abamectin and oxfendazole/levamisole in sheep: effect on marker residues 21 and 28 days after administration.

McKay CH, Baker KE, VanHoff KJ, Smith C, George SD. McKay CH, et al. N Z Vet J. 2024 May;72(3):133-140. doi: 10.1080/00480169.2024.2314494. Epub 2024 Feb 18. N Z Vet J. 2024. PMID: 38369301

2

Oxfendazole Induces Apoptosis in Ovarian Cancer Cells by Activating JNK/MAPK Pathway and Inducing Reactive Oxygen Species Generation.

Chen Y, Wen C, Zhong S, Huang L, Xiang Y, Ou Y, Li L, Tang W, Zhou C, Wu Z, Ye W, Wu S, Huang S, Li Z. Chen Y, et al. Biol Pharm Bull. 2023;46(11):1569-1575. doi: 10.1248/bpb.b23-00349. Biol Pharm Bull. 2023. PMID: 37914359 Free article.

3

Pharmacokinetics and pharmacokinetic interactions of orally administered oxfendazole and oxyclozanide tablet formulation to sheep.

Ozdemir Kutahya Z, Kandir S, Eser Faki H, Uney K, Tras B, Celik M, Torun O. Ozdemir Kutahya Z, et al. J Vet Pharmacol Ther. 2023 Jan;46(1):34-41. doi: 10.1111/jvp.13096. Epub 2022 Oct 3. J Vet Pharmacol Ther. 2023. PMID: 36189621

4

Oxfendazole induces protein catabolism and gluconeogenesis in experimental neurocysticercosis.

Correia LTB, de Lima NF, Gomes TC, De Sousa Guerra CH, Costa TL, Vinaud MC. Correia LTB, et al. Acta Trop. 2022 Oct;234:106571. doi: 10.1016/j.actatropica.2022.106571. Epub 2022 Jun 22. Acta Trop. 2022. PMID: 35752205 Free article.

5

Effects of Ferula asafetida, closantel, albendazole, oxfendazole, and ivermectin against Haemonchus contortus in goats and sheep.

Jabbar A, Iqbal MZ, Ashraf M, Durrani AZ, Sajjad H, Wana MN, Ullah A, Imran M, Ghauri MSZ, Ahmad HI. Jabbar A, et al. Trop Anim Health Prod. 2022 Feb 20;54(2):107. doi: 10.1007/s11250-022-03111-z. Trop Anim Health Prod. 2022. PMID: 35187616

6

Cyathostomin resistance to moxidectin and combinations of anthelmintics in Australian horses.

Abbas G, Ghafar A, Hurley J, Bauquier J, Beasley A, Wilkes EJA, Jacobson C, El-Hage C, Cudmore L, Carrigan P, Tennent-Brown B, Gauci CG, Nielsen MK, Hughes KJ, Beveridge I, Jabbar A. Abbas G, et al. Parasit Vectors. 2021 Dec 4;14(1):597. doi: 10.1186/s13071-021-05103-8. Parasit Vectors. 2021. PMID: 34863271 Free PMC article.

7

Population Pharmacokinetic-Pharmacodynamic Model of Oxfendazole in Healthy Adults in a Multiple Ascending Dose and Food Effect Study and Target Attainment Analysis.

Bach T, Deye GA, Codd EE, Horton J, Winokur P, An G. Bach T, et al. Antimicrob Agents Chemother. 2022 Jan 18;66(1):e0143221. doi: 10.1128/AAC.01432-21. Epub 2021 Oct 4. Antimicrob Agents Chemother. 2022. PMID: 34606333 Free PMC article. Clinical Trial.

8

Efficacy of two locally produced oxfendazole formulations for the treatment of cysticercosis in naturally infected pigs.

Arroyo G, Bustos JA, Calcina JF, Gallegos L, Vargas-Calla A, Gomez-Puerta LA, Lopez T, Gilman RH, Garcia HH, Gonzalez AE; Grupo de Trabajo en Cisticercosis en Perú. Arroyo G, et al. Rev Peru Med Exp Salud Publica. 2021 Apr-Jun;38(2):296-301. doi: 10.17843/rpmesp.2021.382.6539. Epub 2021 Aug 30. Rev Peru Med Exp Salud Publica. 2021. PMID: 34468579 Free PMC article.

9

Exploitation of nanocrystal suspension as an effective oral formulation for oxfendazole.

Sun Y, Chen D, Zhao Y, Zhou K, Zhang B, Wang H, Xie S. Sun Y, et al. Drug Deliv Transl Res. 2022 May;12(5):1219-1229. doi: 10.1007/s13346-021-01012-6. Epub 2021 Jun 20. Drug Deliv Transl Res. 2022. PMID: 34148210

10

Comparing the performance of first-order conditional estimation (FOCE) and different expectation-maximization (EM) methods in NONMEM: real data experience with complex nonlinear parent-metabolite pharmacokinetic model.

Bach T, An G. Bach T, et al. J Pharmacokinet Pharmacodyn. 2021 Aug;48(4):581-595. doi: 10.1007/s10928-021-09753-0. Epub 2021 Apr 21. J Pharmacokinet Pharmacodyn. 2021. PMID: 33884580

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

346 results

Results by year